CytomX Therapeutics (CTMX) Current Assets (2016 - 2025)
Historic Current Assets for CytomX Therapeutics (CTMX) over the last 12 years, with Q3 2025 value amounting to $149.2 million.
- CytomX Therapeutics' Current Assets rose 2016.19% to $149.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was $149.2 million, marking a year-over-year increase of 2016.19%. This contributed to the annual value of $107.3 million for FY2024, which is 4134.29% down from last year.
- Latest data reveals that CytomX Therapeutics reported Current Assets of $149.2 million as of Q3 2025, which was up 2016.19% from $164.6 million recorded in Q2 2025.
- In the past 5 years, CytomX Therapeutics' Current Assets registered a high of $400.0 million during Q1 2021, and its lowest value of $86.6 million during Q1 2025.
- Over the past 5 years, CytomX Therapeutics' median Current Assets value was $200.3 million (recorded in 2022), while the average stood at $204.6 million.
- Data for CytomX Therapeutics' Current Assets shows a peak YoY increase of 2016.19% (in 2025) and a maximum YoY decrease of 4820.36% (in 2025) over the last 5 years.
- Quarter analysis of 5 years shows CytomX Therapeutics' Current Assets stood at $310.3 million in 2021, then decreased by 23.59% to $237.1 million in 2022, then fell by 22.85% to $182.9 million in 2023, then crashed by 41.34% to $107.3 million in 2024, then soared by 39.06% to $149.2 million in 2025.
- Its last three reported values are $149.2 million in Q3 2025, $164.6 million for Q2 2025, and $86.6 million during Q1 2025.